Respiratory Control Unit Sleep Detection Therapy Automation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing inhalable therapy techniques often fail to deliver medication effectively during sleep due to manual activation requirements, leading to missed doses and worsened symptoms upon waking for patients with conditions like COPD.

Innovation Solution

A control unit for a respiratory assist device that automatically triggers the delivery of inhalable therapy based on detection of sleep onset, using predefined time intervals or sleep stages, ensuring continuous relief without disturbing the patient.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If manual activation of inhalable therapy is used, then the subject can control when therapy is delivered, but the therapy is often missed during sleep and symptoms worsen upon waking

Engineering Contradiction:
Improvemanual activation controlVSAvoidtherapy delivery consistency
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The control unit is pre-programmed with scheduled times for inhalable therapy delivery. The system automatically executes therapy delivery at these predetermined times without requiring manual activation, ensuring consistent therapy administration even during sleep periods when the subject would otherwise not activate the device.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system performs self-monitoring and self-execution of therapy delivery based on pre-set parameters. The control unit automatically determines when therapy should be delivered and activates the inhalable therapy device without human intervention, making the system serve itself rather than requiring continuous manual operation by the subject.

Inventive Principle:
Principle #25Self-service

2Reliability

If frequent manual activation is required, then therapy effectiveness is maintained, but it interrupts sleep and prevents rest

Engineering Contradiction:
Improvesymptom relief effectivenessVSAvoidsleep continuity
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The optimal therapy delivery times are determined and programmed in advance before sleep occurs. This preliminary configuration allows the system to automatically deliver therapy at the most effective times without requiring the subject to be awake or actively engage with the device, thus maintaining both effectiveness and sleep continuity.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system incorporates sensors that monitor the subject's respiratory parameters and sleep state. This feedback allows the control unit to automatically adjust and optimize therapy delivery timing based on real-time physiological data, ensuring effective symptom relief while minimizing disturbances to sleep patterns.

Inventive Principle:
Principle #23Feedback

3Reliability

If inhalable therapy is delayed until peak effectiveness time, then symptom relief is optimized, but the delay reduces responsiveness to acute symptoms

Engineering Contradiction:
Improvesymptom relief optimizationVSAvoidtherapy response time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The system employs periodic therapy delivery at multiple scheduled intervals rather than a single delayed dose. By distributing therapy administration across several time points including before sleep, during sleep, and upon waking, the system maintains continuous therapeutic effect without requiring long delays between doses, thus optimizing relief while maintaining responsiveness.

Inventive Principle:
Principle #19Periodic action

Data Source

PatentEP3727536B1Control unit for use with a respiratory assist device
Publication Date: 2022.10.05 KONINKLIJKE PHILIPS NV
  • EP3727536B1 patent drawingFigure 1
  • EP3727536B1 patent drawingFigure 2
  • EP3727536B1 patent drawingFigure 3

AI summary

There is provided a control unit (100) for use with a respiratory assist device (102) that assists a subject (104) with respiration. The control unit (100) configured to detect a time at which delivery of an inhalable therapy to the subject (104) is manually triggered on an inhalable therapy device (106). The control unit (100) is also configured to detect whether the subject (104) has fallen asleep and, on detecting that the subject (104) has fallen asleep, control the inhalable therapy device (106) to automatically trigger delivery of the inhalable therapy to the subject (104) at least a predefined length of time following the detected time at which delivery of the inhalable therapy to the subject (104) is manually triggered.